Complementary Medicines Advance Market Share

Mainstream medicine manufacturers have a continuing headache with the growth of complementary medicine sales in Australia.
And because this is happening, mainstream medicine, through its front-promoter medical organisations, continues to hammer the mantra about lack of evidence and pressure on regulators to prevent the sale of complementary medicines because of a supposed lack of evidence (through outlets such as pharmacy).

Well it seems that consumers are in no doubt because they would not support the products if they were not working for them, nor would they part with their money if they thought they were not getting good value.
While mainstream medicine complains that complementary medicines do not have supportive evidence, they keep very quiet about the falsified “junk evidence” generated to market their own products that have a poor record of efficacy, and in some cases actually cause harm and death.
Mainstream medicine talks only about the management of conditions whereas complementary medicine can actually point to a range of cures.

Pharmacy continues to face criticism from various Skeptic-based groups for selling complementary medicines, and are accused of doing it for the money.
I wonder just how many of those critics have actually had any training in complementary medicines or whether any of them have ever had a patient to treat.

The propaganda from these people is more easily understood when you read the press release below and you realise that many of the critics are in the pay of Big Pharma (and in fact rely on substantial grants to fund their medifraud and their own personal payments).
Has anyone wondered about why Medicines Australia has had to revise its Code of Conduct for members so many times. and yet still can’t get unqualified approval from the ACCC in regard to clauses covering payments made by some members to doctors?

It’s good to see consumers taking more control over their health and this trend will continue into the future.
The following was released by Complementary Medicines Australia:

Complementary Medicines Industry revenue has grown 54 per cent to $3.5 billion over the past five years, as revealed by the 2014 Complementary Medicines Industry Survey. The results were published at the recent launch of Complementary Medicines Australia (previously Complementary Healthcare Council of Australia).

“The 2014 Complementary Medicines Industry Survey provides a health check on the growth of the complementary medicines industry, and sets out the challenges of operating a business in Australia, examining the issues that constrain further growth,” said Mr Carl Gibson, CEO of Complementary Medicines Australia.

“The survey results indicate that the complementary medicines industry in Australia is healthy and growing in spite of the strong currency, excessive regulatory burden and lingering effects of the Global Financial Crisis. In fact, additional research shows that industry revenue, which now stands at $3.5 billion, is expected to grow to $4.6 billion in 2017-2018, and the industry expects an increase of 45,000 employees over the same period.”

Industry survey highlights included:

$3.5 billion complementary medicines industry revenue, expected to grow to $4.6 billion in 2017-2018;

83 per cent of complementary medicine companies are expecting to grow their business over the next three years;

45,000 extra jobs as 58 per cent of companies are expected to have a growth in employee numbers during the next three years;

62 per cent of complementary medicines companies engaged in the export business;

8 out of 10 ten countries Australia exports to, are in the Asia-Pacific region; and

 “Excessive regulatory burden” is the top business burden restricting growth while “high operation costs / primary services” are hampering the export potential of manufacturers.

“In total, 156 companies participated in the survey during November 2013 to June 2014, with representation of a number of industry sectors, including importers, exporters, manufacturers, raw material suppliers, wholesalers, sponsors, distributors, health-food retailers and consultants.”

Click on this image for a sharper and larger version

  • GM Bread-smallThe pervasive spread of health risks continues with the introduction of GM foods more widely into the Australian food chain to sit alongside the chemicals presents through herbicides, insecticides, preservatives and fertilisers.

At least the Australian food manufacturers/distributors have started listing GM components on their labels which enables consumers to make their own informed choices and exercise control over their health and well-being.
This is an area of health education not easily available to pharmacists or their educators, but it is a major source of so-called lifestyle illness – and these illnesses will become more widespread as the food chain becomes more adulterated than it already is.
Pharmacists are encouraged to learn as much as possible about food contaminants and their effect on human health.
It is pleasing to note that some Australian food manufacturers and distributors(like Buttercup Bread) are labelling GM foods unlike their US counterparts. But it is not so pleasing that they choose to use GM ingredients when healthier and more natural alternatives exist, or that they feel the need to import GM food made in the US, for distribution in Australia.

Pharmacies also need a closer association with food distribution to help patients with specific conditions to make healthier choices.
Food lists containing warnings also need to be prepared, for all foods known to have actual or potential adverse reactions with human health.
Mainstream medicine is not likely to produce solutions for lifestyle illnesses because it often has an association with the primary cause, in the form of an agricultural chemical in the inventory mix.

They have already been accused of inventing illnesses so as to design more drugs to treat patients, so it’s not such a distance to see illness being manufactured through food chain adulteration.
Would they produce drugs to combat lifestyle illness and draw attention to the perpetual market they have spawned?

Given recent revelations regarding some vaccine manufacturers and the falsification of evidence at the highest levels of a US pharma and the US agency designed to protect human health, the Centre for Disease Control (CDC), it seems there is no limit to the low level that these people will stoop to.
I2P plans to publish more about this in coming editions and expose just how criminally corrupt the global drug industry has become.

2 responses to “Complementary Medicines Advance Market Share”

  1. Since the report in Europe some years ago, followed shortly thereafter by similar figures from US and Australia, of sales of non-pharmaceutical products for ‘health’ issues equaling or exceeding ‘mainstream’products, there was a ramp-up of the ‘unproven/unscientific’ claims by the spin doctors for Big Pharma. But immediately the buy-up of the companies producing nutritional products began, and very few are now independent. As this has happened, dosages of the active components has dropped, and many of the herbal ingredients are made from the less vital parts of the plant. So, by making weak products that are contrary to herbal protocols, they make money from less-discerning clients, and can then also say, ‘just as we told you,this stuff does not work’.

  2. great article – the regulatory ecosystem in aussie is progressive and pro-business – if “mainstream” drug companies can’t deliver products that consumers want, then they either progress or fail – good luck to them!

Leave a Reply

Your email address will not be published. Required fields are marked *